Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | 93618484@qq.com |
| QQ: | 2885503023 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Febuxostat Impurity E | C17H18N2O3S | 923942-34-1 | Details |
| Febuxostat Impurity 40 | C7H7NOS | 7133-90-6 | Details |
| 2-(5-cyano-2-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid | C12H13NO3 | 528607-60-5 | Details |
| 4-Hydroxyisophthalonitrile | C8H4N2O | 34133-58-9 | Details |
| Febuxostat Impurity 41;4-hydroxybenzothioamide | C19H19N3O3S | 2428631-67-6 | Details |
| Febuxostat Impurity 48;diethyl 2,2'-(4-formyl-6-hydroxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylate) | C18H20N2O3S | 2375033-35-3 | Details |
| 5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester | C19H21NO5S | 2375033-26-2 | Details |
| ethyl 2-(3-formyl-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylate | C18H20N2O3S | 2230270-05-8 | Details |
| ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate | C15H13NO5S | 2073891-59-3 | Details |
| Febuxostat Impurity Z17 | C14H13NO4S | 161798-01-2 | Details |
| Febuxostat Intermediate | C18H20N2O3S | 160844-75-7 | Details |
| 1,3-Benzenedicarbonitrile, 4-ethoxy- | C10H8N2O | 161718-82-7 | Details |
| Febuxostat Impurity 47 | C12H14N2O2 | 161718-85-0 | Details |
| Febuxostat Impurity 3 | C14H12N2O3S | 161798-02-3 | Details |
| Ethyl2-(3-Formyl-4-isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate | C18H21NO4S | 161798-03-4 | Details |
| 5-Thiazolecarboxylic acid, 2-(4-hydroxy-3-methylphenyl)-4-methyl-, ethyl ester | C14H15NO3S | 1621995-80-9 | Details |
| ethyl 2-(3-formyl-2-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | C12H12N2O | 1805770-41-5 | Details |
| Febuxostat Impurity 6 | C17H21NO3S | 144060-97-9 | Details |
| Febuxostat Impurity 55 | C17H18N2O3S | 144060-84-4 | Details |
| Febuxostat | C16H16N2O3S | 144060-53-7 | Details |
| 11-Oxo-betaMethasone Dipropionate | C28H35FO7 | 64967-90-4 | Details |
| Clobetasone Butyrate EP Impurity I | C26H32ClFO5 | 639817-47-3 | Details |
| 2-amino-2-(2-chlorophenyl)acetamide | C8H9ClN2O | 1198220-10-8 | Details |
| Ticagrelor Impurity16 | C7H10ClN3S | 2518048-22-9 | Details |
| (S)-2-(3,4-Difluorophenyl)oxirane | C8H6F2O | 1006376-63-1 | Details |
| INDEX NAME NOT YET ASSIGNED | C18H24ClN7O4S2 | 2681352-85-0 | Details |
| (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | C14H21N5O5S | 1445580-43-7 | Details |
| (1R)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol | C8H7ClF2O | 1212376-05-0 | Details |
| Prednisolone, 9-bromo-6.alpha.-methyl-, 21-acetate | C24H31BrO6 | 93052-90-5 | Details |
| Clopidogrel Impurity 13 HCl;methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride | C16H16ClNO5S2 | 2173294-69-2 | Details |
| 4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine | C7H9Cl2N3OS | 1823431-32-8 | Details |
| Pregna-1,4,9(11)-triene-3,20-dione, 17-hydroxy- | C21H26O3 | 30934-01-1 | Details |
| 1-Piperazinecarboxaldehyde, 4-[2-[(2,4-dimethylphenyl)sulfinyl]phenyl]- | C19H22N2O2S | 2425618-48-8 | Details |
| Pregna-1,4-diene-3,11,20-trione, 17-(acetyloxy)-21-hydroxy- | C23H28O6 | 95440-71-4 | Details |
| Hydrocortisone impurity J (EP) | C23H32O6 | 16463-74-4 | Details |
| Fluorometholone Impurity 5 | C22H29BrO4 | 110664-58-9 | Details |
| 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-, ethyl ester, (4R,5S)-rel- | C22H32N2O6 | 2434599-55-8 | Details |
| Epoxy Metradiene | C22H28O4 | 83873-16-9 | Details |
| Prednisone 17, 21-Diacetate | C25H30O7 | 6677-19-6 | Details |
| Cetirizine IMpurity D | C30H28Cl2N2 | 346451-15-8 | Details |
| 5-Methoxy-2-mercaptobenzimidazole | C8H8N2OS | 37052-78-1 | Details |
| Omeprazole Sulfide | C17H19N3O2S | 73590-85-9 | Details |
| Homopiperazine | C5H12N2 | 505-66-8 | Details |
| Esomeprazole Impurity 29 | C16H17N3OS | 704910-89-4 | Details |
| 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide | C17H19N3O3S | 142885-92-5 | Details |
| 2-(((6-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5- dimethylpyridin-4-ol | C16H17N3O2S | 103876-98-8 | Details |
| 2-(Chloromethyl)-3,5-dimethylpyridin-4-ol | C8H10ClNO | 220771-03-9 | Details |
| 2-Mercapto-1H-benzo[d]imidazol-5-ol | C7H6N2OS | 92806-98-9 | Details |
| Omeprazole Impurity 8 | C9H12ClNO2 | 848694-10-0 | Details |
| 4,5''-Di(desmethyl) Omeprazole Sulfide | C15H15N3O2S | 176219-12-8 | Details |
| 2-[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5- methoxy-1H-benzimidazole | C16H17N3O2S | 110374-16-8 | Details |
| Omeprazole Impurity 1 | C16H17N3O2S | 103877-02-7 | Details |
| OmeprazolesulfoneN-Oxide | C17H19N3O5S | 158812-85-2 | Details |
| Parecoxib Impurity E | C16H15N3O5S2 | 1373038-59-5 | Details |
| OmeprazoleN-oxide | C17H19N3O4S | 176219-04-8 | Details |
| 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | C16H20N6O | 477600-75-2 | Details |
| 3-[(3R,4R)-3-({2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl}(methyl)amino)-4-methylpiperidin-1-yl]-3-oxopropanenitrile | C16H19ClN6O | 1616761-00-2 | Details |
| Tipiracil Impurity 2 | C9H10ClN3O3 | 2101241-71-6 | Details |
| Tofacitinib Impurity 5 | C13H18ClN5 | 2250243-18-4 | Details |
| (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine | C13H18ClN5 | 2504210-32-4 | Details |
| 2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo [2,3-d]pyrimidin-4-amine | C13H18ClN5 | 1616760-97-4 | Details |
| 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole | C17H18N3O4ST | 1810066-05-7 | Details |
| 4-(5-Methyl-3-phenylisoxazol-4-yl)-N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)benzenesulfonamide(PalbociclibImpurity) | C32H25N3O6S2 | 1373038-60-8 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide(PalbociclibImpurity) | C20H20N2O4S | 198470-91-6 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyramide(PalbociclibImpurity) | C20H20N2O4S | 198470-82-5 | Details |
| Parecoxib Impurity B | C16H13NO4S | 181696-35-5 | Details |
| Valdecoxib | C16H14N2O3S | 181695-72-7 | Details |
| Parecoxib Impurity C（Valdecoxib Impurity） | C18H16N2O4S | 198471-06-6 | Details |
| Parecoxib Impurity | C17H15NO4S | 2749361-92-8 | Details |
| Parecoxib Impurity 21 | C18H17NO4S | 1884279-18-8 | Details |
| Pyrido[3,2-d]pyrimidin-6(5H)-one, 5-cyclopentyl-8-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- | C22H27N7O | 2745066-17-3 | Details |
| Ethyl2-oxo-2-(pyridin-2-ylamino)acetate(EdoxabanImpurity) | C9H10N2O3 | 41374-72-5 | Details |
| 1-Boc-4-(6-nitropyridin-3-yl)piperazine | C14H20N4O4 | 571189-16-7 | Details |
| 1-(6-Nitropyridin-3-yl)piperazine | C9H12N4O2 | 775288-71-6 | Details |
| Benzonitrile, 2-[[6-[(3R)-3-[[(2-cyano-5-fluorophenyl)methyl]amino]-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro- | C26H24F2N6O2 | 2412663-46-6 | Details |
| Trelagliptin Impurity | C15H14FN3O3 | 1938080-43-3 | Details |
| Trelagliptin Impurity | C14H12FN3O3 | 2088203-83-0 | Details |
| Trelagliptin Impurity | C23H31N7O2 | 1917324-14-1 | Details |
| Trelagliptin Impurity 3 | C18H20FN5O2 | 1812193-01-3 | Details |
| Trelagliptin Impurity 5 | C22H24FN5O5 | 2087874-92-6 | Details |
| Trelagliptin Impurity X | C18H22FN5O3 | 1938080-44-4 | Details |
| Trelagliptin Impurity 5 | C13H16FN3 | 1971613-57-6 | Details |
| Trelagliptin Impurity S | C18H21FN4O4 | 1917324-15-2 | Details |
| 1H-Imidazole, 1-[2-(ethylsulfinyl)ethyl]-2-methyl-5-nitro- | C8H13N3O3S | 2376335-05-4 | Details |
| Tinidazole Impurity B | C8H13N3O4S | 25459-12-5 | Details |
| Glycine,N-(aminoiminomethyl)-N-methyl-, ethyl ester | C6H13N3O2 | 15366-29-7 | Details |
| Ambroxol EP Impurity B | C14H19Br2ClN2O | 15942-08-2 | Details |
| 5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetra hydrothieno[3,2-c]pyridin-2(4H)-one | C18H18FNO2S | 150322-38-6 | Details |
| N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine | C11H21N5O6 | 50913-12-7 | Details |
| Argatroban impurity J | C10H8ClNO2S | 1780572-69-1 | Details |
| 1-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-ethanone | C15H21N5O | 344418-61-7 | Details |
| Argatroban Impurity 6 | C10H8ClNO2S | 94975-84-5 | Details |
| 1H-Pyrazole-5-carboxamide, 4-[[2-hydroxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino]-1-methyl-3-propyl- | C20H28N6O5S | 960009-36-3 | Details |
| Testosterone Propionate EP Impurity B | C23H34O3 | 1169-49-9 | Details |
| glycylglycocholicacid | C28H46N2O7 | 26563-58-6 | Details |
| MEDROXYPROGESTERONE | C22H32O3 | 520-85-4 | Details |
| Gonan-3-one, 17-hydroxy-, (5α,17β)- (9CI) | C17H26O2 | 200056-72-0 | Details |
| 16alpha-Hydroxyprednisonlone acetate | C23H30O7 | 86401-80-1 | Details |
| 5-CHLOROSULFONYL-2-ETHOXYBENZOIC ACID | C9H9ClO5S | 200575-16-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 | ||||